Nuts and bolts of economic studies alongside clinical trials Newsletter Article 09 February 2013 Pages: 2 - 2
US FDA patient information initiative to lower costs Newsletter Article 09 February 2013 Pages: 2 - 2
Clinical practice guidelines inadequate in Australia? Newsletter Article 09 February 2013 Pages: 4 - 4
‘Prediction rule’ may reduce hospitalisations for pneumonia Newsletter Article 09 February 2013 Pages: 5 - 5
Urokinase vs streptokinase for complicated pleural effusions Newsletter Article 09 February 2013 Pages: 5 - 5
Single-dose azithromycin cost saving in nongonococcal urethritis Newsletter Article 09 February 2013 Pages: 6 - 7
Drug formularies should be encouraged in general practice Newsletter Article 09 February 2013 Pages: 7 - 7
Acadesine reduces adverse outcomes and costs in CABG Newsletter Article 09 February 2013 Pages: 9 - 9
Guidelines fail to improve outcomes in diabetic ketoacidosis Newsletter Article 09 February 2013 Pages: 10 - 10
Most cost-effective H. pylori eradication therapy identified Newsletter Article 09 February 2013 Pages: 10 - 10
Does antidepressant treatment reduce resource use? Newsletter Article 09 February 2013 Pages: 10 - 11
Italian government aims to stop drug price shuffle Newsletter Article 09 February 2013 Pages: 11 - 11
US patients frustrated with their healthcare system Newsletter Article 09 February 2013 Pages: 11 - 11
Continuity of care generates positive health outcomes Newsletter Article 09 February 2013 Pages: 11 - 12